Martina Živná1, Kendrah Kidd2, Anna Přistoupilová1, Veronika Barešová1, Mathew DeFelice3, Brendan Blumenstiel3, Maegan Harden3, Peter Conlon4,5, Peter Lavin6, Dervla M Connaughton4,6, Hana Hartmannová1, Kateřina Hodaňová1, Viktor Stránecký1, Alena Vrbacká1, Petr Vyleťal1, Jan Živný7, Miroslav Votruba1, Jana Sovová1, Helena Hůlková1,8, Victoria Robins2, Rebecca Perry2, Andrea Wenzel9,10, Bodo B Beck9,10, Tomáš Seeman11, Ondřej Viklický12, Sylvie Rajnochová-Bloudíčková12, Gregory Papagregoriou13, Constantinos C Deltas13, Seth L Alper14, Anna Greka3,15,16, Anthony J Bleyer17,2, Stanislav Kmoch1,2. 1. Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine. 2. Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. 4. Department of Nephrology, Beaumont Hospital, Dublin, Ireland. 5. Royal College of Surgeons, Dublin, Ireland. 6. Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland. 7. Institute of Pathophysiology, First Faculty of Medicine. 8. Institute of Pathology, First Faculty of Medicine, and. 9. Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany. 10. Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany. 11. Department of Paediatrics, Second Faculty of Medicine, Charles University, Prague, Czech Republic. 12. Nephrology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 13. Molecular Medicine Research Center, Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus. 14. Division of Nephrology and Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 15. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and. 16. Department of Medicine, Harvard Medical School, Boston, Massachusetts. 17. Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, ableyer@wakehealth.edu.
Abstract
BACKGROUND: Autosomal dominant tubulointerstitial kidney disease caused by mucin-1 gene (MUC1) mutations (ADTKD-MUC1) is characterized by progressive kidney failure. Genetic evaluation for ADTKD-MUC1 specifically tests for a cytosine duplication that creates a unique frameshift protein (MUC1fs). Our goal was to develop immunohistochemical methods to detect the MUC1fs created by the cytosine duplication and, possibly, by other similar frameshift mutations and to identify novel MUC1 mutations in individuals with positive immunohistochemical staining for the MUC1fs protein. METHODS: We performed MUC1fs immunostaining on urinary cell smears and various tissues from ADTKD-MUC1-positive and -negative controls as well as in individuals from 37 ADTKD families that were negative for mutations in known ADTKD genes. We used novel analytic methods to identify MUC1 frameshift mutations. RESULTS: After technique refinement, the sensitivity and specificity for MUC1fs immunostaining of urinary cell smears were 94.2% and 88.6%, respectively. Further genetic testing on 17 families with positive MUC1fs immunostaining revealed six families with five novel MUC1 frameshift mutations that all predict production of the identical MUC1fs protein. CONCLUSIONS: We developed a noninvasive immunohistochemical method to detect MUC1fs that, after further validation, may be useful in the future for diagnostic testing. Production of the MUC1fs protein may be central to the pathogenesis of ADTKD-MUC1.
BACKGROUND:Autosomal dominant tubulointerstitial kidney disease caused by mucin-1 gene (MUC1) mutations (ADTKD-MUC1) is characterized by progressive kidney failure. Genetic evaluation for ADTKD-MUC1 specifically tests for a cytosine duplication that creates a unique frameshift protein (MUC1fs). Our goal was to develop immunohistochemical methods to detect the MUC1fs created by the cytosine duplication and, possibly, by other similar frameshift mutations and to identify novel MUC1 mutations in individuals with positive immunohistochemical staining for the MUC1fs protein. METHODS: We performed MUC1fs immunostaining on urinary cell smears and various tissues from ADTKD-MUC1-positive and -negative controls as well as in individuals from 37 ADTKD families that were negative for mutations in known ADTKD genes. We used novel analytic methods to identify MUC1 frameshift mutations. RESULTS: After technique refinement, the sensitivity and specificity for MUC1fs immunostaining of urinary cell smears were 94.2% and 88.6%, respectively. Further genetic testing on 17 families with positive MUC1fs immunostaining revealed six families with five novel MUC1 frameshift mutations that all predict production of the identical MUC1fs protein. CONCLUSIONS: We developed a noninvasive immunohistochemical method to detect MUC1fs that, after further validation, may be useful in the future for diagnostic testing. Production of the MUC1fs protein may be central to the pathogenesis of ADTKD-MUC1.
Authors: Simon Staubach; Andrea Wenzel; Bodo B Beck; Markus M Rinschen; Stefan Müller; Franz-Georg Hanisch Journal: Proteomics Date: 2018-03-13 Impact factor: 3.984
Authors: P Vylet'al; M Kublová; M Kalbácová; K Hodanová; V Baresová; B Stibůrková; J Sikora; H Hůlková; J Zivný; J Majewski; A Simmonds; J-P Fryns; G Venkat-Raman; M Elleder; S Kmoch Journal: Kidney Int Date: 2006-08-02 Impact factor: 10.612
Authors: Brendan Blumenstiel; Matthew DeFelice; Ozge Birsoy; Anthony J Bleyer; Stanislav Kmoch; Todd A Carter; Andreas Gnirke; Kendrah Kidd; Heidi L Rehm; Lucienne Ronco; Eric S Lander; Stacey Gabriel; Niall J Lennon Journal: J Mol Diagn Date: 2016-05-05 Impact factor: 5.568
Authors: Martina Zivná; Helena Hůlková; Marie Matignon; Katerina Hodanová; Petr Vylet'al; Marie Kalbácová; Veronika Baresová; Jakub Sikora; Hana Blazková; Jan Zivný; Robert Ivánek; Viktor Stránecký; Jana Sovová; Kathleen Claes; Evelyne Lerut; Jean-Pierre Fryns; P Suzanne Hart; Thomas C Hart; Jeremy N Adams; Audrey Pawtowski; Maud Clemessy; Jean-Marie Gasc; Marie-Claire Gübler; Corinne Antignac; Milan Elleder; Katja Kapp; Philippe Grimbert; Anthony J Bleyer; Stanislav Kmoch Journal: Am J Hum Genet Date: 2009-08-06 Impact factor: 11.025
Authors: Samuel Mon-Wei Yu; Anthony J Bleyer; Kisra Anis; Leal Herlitz; Martina Živná; Helena Hůlková; Glen S Markowitz; Belinda Jim Journal: Am J Kidney Dis Date: 2017-12-06 Impact factor: 8.860
Authors: Anthony J Bleyer; Arch S Woodard; Zak Shihabi; Jaspreet Sandhu; Honping Zhu; Scott G Satko; Nelson Weller; Elizabeth Deterding; Debra McBride; Michael C Gorry; Linda Xu; Deann Ganier; Thomas C Hart Journal: Kidney Int Date: 2003-07 Impact factor: 10.612
Authors: Anthony J Bleyer; Matthias T Wolf; Kendrah O Kidd; Martina Zivna; Stanislav Kmoch Journal: Pediatr Nephrol Date: 2021-05-22 Impact factor: 3.651
Authors: Petr Vylet'al; Kendrah Kidd; Hannah C Ainsworth; Drahomíra Springer; Alena Vrbacká; Anna Přistoupilová; Rebecca P Hughey; Seth L Alper; Niall Lennon; Steven Harrison; Maegan Harden; Victoria Robins; Abbigail Taylor; Lauren Martin; Katrice Howard; Ibrahim Bitar; Carl D Langefeld; Veronika Barešová; Hana Hartmannová; Kateřina Hodaňová; Tomáš Zima; Martina Živná; Stanislav Kmoch; Anthony J Bleyer Journal: Am J Nephrol Date: 2021-06-07 Impact factor: 3.754
Authors: S Cormican; D M Connaughton; C Kennedy; S Murray; M Živná; S Kmoch; N K Fennelly; P O'Kelly; K A Benson; E T Conlon; G Cavalleri; C Foley; B Doyle; A Dorman; M A Little; P Lavin; K Kidd; A J Bleyer; P J Conlon Journal: Ren Fail Date: 2019-11 Impact factor: 2.606